Healthy Living/WellnessFDA shows no love for Johnson & Johnson Xarelto blood thinner, rejects expanded use for 3rd time The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time.by Randell Suba
Healthy Living/WellnessMade in India drugs come under FDA scanner over safety concernsby James Maynard
Healthy Living/WellnessFDA set to launch $115 million anti-tobacco ad campaign targeting teen smokersby Sumit Passary
Healthy Living/WellnessNutrition label makeover proposed by FDA will make it easier to understand and more usefulby Maryanne Moll
Healthy Living/WellnessThe caramel color in your cola may kill you, Consumer Reports warnsby Rhodilee Jean Dolor
Apple to Release iOS 18.2 Earlier This December, Featuring Siri's ChatGPT, Apple Intelligence Upgrades